Clin2
NCT02880163Possibly a fitRecruiting

Test foam used to stop dangerous internal abdominal bleeding

Hemorrhagic ShockTraumaExsanguinating HemorrhageShock; Traumatic

Part of Injuries & trauma clinical trials.

This trial tests whether an expandable foam can quickly help slow or control life-threatening bleeding inside the belly. It is designed for emergency situations where surgery to stop the bleeding will happen soon.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
15 years and older
Study type
Interventional

Who can take part

  • You’re at least 15 years old (or estimated weight over 50 kg if age is unknown)
  • You’re in an emergency with severe bleeding shock from a belly (abdominal) source
  • Doctors confirm the bleeding is in the abdomen (by seeing it, an ultrasound test, or a procedure that samples fluid from the belly)
  • There is no other ongoing, uncontrolled bleeding source besides the abdomen
  • You must be on a breathing machine and sedated, and doctors decide within 30 minutes of arriving at the ER

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06070350Recruiting· Phase 3
Massive transfusion for life-threatening bleeding in children

This study tests whether adding the drug tranexamic acid (TXA) to a massive blood transfusion helps control life-threatening bleeding in children who are severely injured. It compares two groups: one gets TXA and the other gets a placebo (a dummy drug with no active ingredient).

Tucson, Arizona
NCT05634109Recruiting· Phase 3
Whole blood to treat adults with severe bleeding trauma

This trial compares giving whole blood versus standard care in adults with severe trauma and dangerous blood loss (hemorrhagic shock). The goal is to see if whole blood helps stabilize patients faster and improves outcomes after major bleeding.

Cali, Valle del Cauca Department
NCT07218185Enrolling by invitation
Fibrinogen treatment for severe bleeding after trauma

This study tests an investigational treatment called INTERCEPT Fibrinogen Complex (IFC) for people with severe bleeding after a traumatic injury. The treatment helps restore a key blood-clotting protein to try to stop the bleeding and improve survival.

Aurora, Colorado
NCT05958342Recruiting· Phase 2
Calcium and vasopressin for bleeding shock after major injury

This trial tests whether giving calcium and vasopressin early can improve outcomes in people with major injury who are at risk for life-threatening bleeding shock. It mainly includes patients who need rapid blood transfusion and likely major surgery to stop bleeding.

Chandler, Arizona
NCT06622317Recruiting
Belt to stop severe lower body bleeding

This trial tests a special belt (AAJT-S) that is wrapped around the belly to stop severe bleeding from the lower body (like from a bad car crash or fall). It's for people who are bleeding so much that their body is not getting enough blood, and it aims to buy time until surgery.

Graz, Styria
NCT07274150Not yet recruiting
Emergency tourniquet for severe lower-body bleeding

This trial tests a special tourniquet for the belly area (AAJT-S) that may help control severe bleeding from lower-body injuries before or during hospital care. It aims to find out if this device can save lives when standard pressure methods cannot stop the bleeding.

Graz, Styria

Hear when a new Hemorrhagic Shock trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.